| 04/13/2026 3:51 PM | Athira Pharma (1620463) Issuer San Martin Javier (1794629) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/13/2026 3:52 PM | EDELMAN JOSEPH (1164426) Reporting Athira Pharma (1620463) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/13/2026 3:53 PM | JOHNSON JAMES A (1225501) Reporting Athira Pharma (1620463) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/13/2026 3:54 PM | Athira Pharma (1620463) Issuer Romano Kelly A (1722055) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/13/2026 3:55 PM | Athira Pharma (1620463) Issuer PICKERING GRANT (1258693) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/13/2026 3:56 PM | Kosacz Barbara (1763316) Reporting Athira Pharma (1620463) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/13/2026 3:58 PM | CHURCH KEVIN (1822499) Reporting Athira Pharma (1620463) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/13/2026 3:59 PM | Athira Pharma (1620463) Issuer Panzara Michael A. (1679039) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/13/2026 3:46 PM | Athira Pharma (1620463) Issuer Litton Mark James (1604834) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/13/2026 3:47 PM | Athira Pharma (1620463) Issuer Renninger Robert (2037968) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/13/2026 3:48 PM | Athira Pharma (1620463) Issuer Worthington Mark (1861464) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for LONA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Athira Pharma and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/13/2026 3:49 PM | FLUKE JOHN M JR (1191906) Reporting Athira Pharma (1620463) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 8:30 PM | Athira Pharma (1620463) Filer | Form 424B3 | |
| 04/01/2026 8:30 PM | Athira Pharma (1620463) Filer | Form 424B3 | |
| 04/01/2026 11:15 PM | Athira Pharma (1620463) Filer | Form EFFECT | |
| 04/01/2026 11:15 PM | Athira Pharma (1620463) Filer | Form EFFECT | |
| 04/01/2026 3:05 PM | Athira Pharma (1620463) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 04/01/2026 3:07 PM | Athira Pharma (1620463) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/31/2026 3:59 PM | Athira Pharma (1620463) Filer | Form S-1/A | |
| 03/31/2026 4:07 PM | Athira Pharma (1620463) Filer | Form S-1/A | |
| 03/31/2026 3:11 PM | Athira Pharma (1620463) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/31/2026 1:20 PM | Athira Pharma (1620463) Filer | Form 8-K/A | |
| 03/19/2026 3:50 PM | Athira Pharma (1620463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/10/2026 3:20 PM | Athira Pharma (1620463) Filer | Form DEFR14A | |
| 03/05/2026 6:14 PM | Athira Pharma (1620463) Issuer Litton Mark James (1604834) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 5:59 PM | Athira Pharma (1620463) Issuer San Martin Javier (1794629) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 6:02 PM | CHURCH KEVIN (1822499) Reporting Athira Pharma (1620463) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 6:06 PM | Athira Pharma (1620463) Issuer Worthington Mark (1861464) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 6:10 PM | Athira Pharma (1620463) Issuer Renninger Robert (2037968) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 6:47 PM | Athira Pharma (1620463) Subject Litton Mark James (1604834) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/06/2026 3:29 PM | Baselake Partners, LP (1957912) Filed by Athira Pharma (1620463) Subject | Form SCHEDULE 13G/A | |
| 02/04/2026 3:53 PM | Athira Pharma (1620463) Filer | Form PRE 14A | |
| 01/20/2026 3:42 PM | Athira Pharma (1620463) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 01/16/2026 3:46 PM | Athira Pharma (1620463) Subject PERCEPTIVE ADVISORS LLC (1224962) Filed by | Form SCHEDULE 13D/A | |
| 01/09/2026 3:05 PM | Athira Pharma (1620463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/08/2026 4:29 PM | ACORN BIOVENTURES, L.P. (1766853) Filed by Athira Pharma (1620463) Subject | Form SCHEDULE 13G/A | |
| 01/05/2026 6:49 PM | Athira Pharma (1620463) Issuer Worthington Mark (1861464) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/05/2026 6:50 PM | Athira Pharma (1620463) Issuer CHURCH KEVIN (1822499) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/05/2026 6:50 PM | Athira Pharma (1620463) Issuer Renninger Robert (2037968) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/05/2026 6:51 PM | Athira Pharma (1620463) Issuer Litton Mark James (1604834) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/05/2026 6:52 PM | Athira Pharma (1620463) Issuer San Martin Javier (1794629) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
|
| 12/29/2025 3:12 PM | Athira Pharma (1620463) Issuer Worthington Mark (1861464) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 3:14 PM | Athira Pharma (1620463) Issuer San Martin Javier (1794629) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 3:15 PM | Athira Pharma (1620463) Issuer CHURCH KEVIN (1822499) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 3:17 PM | Athira Pharma (1620463) Issuer Litton Mark James (1604834) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 3:19 PM | Athira Pharma (1620463) Issuer Renninger Robert (2037968) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 4:16 PM | Athira Pharma (1620463) Subject PERCEPTIVE ADVISORS LLC (1224962) Filed by | Form SCHEDULE 13D/A | |
| 12/23/2025 4:12 PM | Athira Pharma (1620463) Issuer EDELMAN JOSEPH (1164426) Reporting PERCEPTIVE ADVISORS LLC (1224962) Reporting PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (1249675) Reporting Perceptive Xontogeny Venture Fund II, LP (1851820) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 3:46 PM | ACORN BIOVENTURES, L.P. (1766853) Filed by Athira Pharma (1620463) Subject | Form SCHEDULE 13G | |
| 12/22/2025 3:30 PM | Athira Pharma (1620463) Subject PERCEPTIVE ADVISORS LLC (1224962) Filed by | Form SCHEDULE 13D/A | |
| 12/18/2025 2:47 PM | Athira Pharma (1620463) Subject BML Investment Partners, L.P. (1373604) Filed by | Form SCHEDULE 13G/A | |
| 12/18/2025 7:24 AM | Athira Pharma (1620463) Filer | Form 8-K/A | |
| 12/18/2025 6:16 AM | Athira Pharma (1620463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 3:06 PM | Athira Pharma (1620463) Subject Baselake Partners, LP (1957912) Filed by | Form SCHEDULE 13G | |
| 11/06/2025 3:09 PM | Athira Pharma (1620463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/06/2025 3:13 PM | Athira Pharma (1620463) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/10/2025 3:41 PM | Athira Pharma (1620463) Subject Oliveira Steven Michael (1358629) Filed by | Form SCHEDULE 13G/A | |
| 10/03/2025 8:11 AM | Athira Pharma (1620463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/11/2025 8:00 AM | Athira Pharma (1620463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/02/2025 3:32 PM | Athira Pharma (1620463) Issuer Renninger Robert (2037968) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2025 3:33 PM | Athira Pharma (1620463) Issuer Worthington Mark (1861464) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2025 3:33 PM | Athira Pharma (1620463) Issuer San Martin Javier (1794629) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2025 6:33 PM | Athira Pharma (1620463) Subject Worthington Mark (1861464) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/01/2025 6:34 PM | Athira Pharma (1620463) Subject CHURCH KEVIN (1822499) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/01/2025 6:36 PM | Athira Pharma (1620463) Subject San Martin Javier (1794629) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/01/2025 6:37 PM | Athira Pharma (1620463) Subject Litton Mark James (1604834) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/03/2025 4:32 PM | Athira Pharma (1620463) Issuer PICKERING GRANT (1258693) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2025 4:33 PM | Athira Pharma (1620463) Issuer Kosacz Barbara (1763316) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2025 4:34 PM | Athira Pharma (1620463) Issuer JOHNSON JAMES A (1225501) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2025 4:34 PM | Athira Pharma (1620463) Issuer EDELMAN JOSEPH (1164426) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2025 4:35 PM | Athira Pharma (1620463) Issuer Romano Kelly A (1722055) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2025 4:36 PM | Athira Pharma (1620463) Issuer Panzara Michael A. (1679039) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2025 4:37 PM | Athira Pharma (1620463) Issuer FLUKE JOHN M JR (1191906) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/09/2025 3:15 PM | Athira Pharma (1620463) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |